Clinical Trial Update: Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria [Phase 2]

View source ↗

Summary

Miltefosine was evaluated in a Phase 2 trial for antihistamine-resistant chronic urticaria; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Marcus Maurer | Conditions: Chronic Urticaria | Phase 2 | Status: TERMINATED | Results posted: 2016-12-26